Venrock Adviser, LLC — 13F Holdings

2026 Q3  ·  40 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Venrock Adviser, LLC maintained a portfolio of 40 distinct positions. The most significant new addition was KORSANA BIOSCIENCES INC, now representing 7.07% of the total fund value. They heavily accumulated shares in ERASCA INC, increasing the position by 12.3%. Conversely, Venrock Adviser, LLC completely exited their position in APOGEE THERAPEUTICS INC.
Position History hover any row below to update
Loading…
Venrock Adviser, LLC Houston, TX Hedge Fund / Investment Adviser AUM $2,058M
PCA Score Concentration Risk
Risk ENB
Total Positions
40
Quarter
2026 Q3
Top Holding
ORKA (16.8%)
Top 10 Concentration
71.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-40 of 40

Venrock Adviser, LLC Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
ORKA
ORUKA THERAPEUT...
Healthcare 16.79% 11.97% #1 1
Prev: #2
7.0
—
no change no change
P
S
4,148,428 $345,522,568
$21.30 +365.9%
$83.29 +19.1%
2024 Q3 13F Filing 2026-09-30 2026-11-16
ERAS
ERASCA INC
Healthcare 14.31% 9.94% #2 1
Prev: #3
7.5
—
2,198,120 12.3%
P
S
20,089,932 $294,518,403
$4.65 +198.9%
$14.66 -5.3%
2024 Q2 13F Filing 2026-09-30 2026-11-16
SYRE
SPYRE THERAPEUT...
Healthcare 10.75% 8.04% #3 1
Prev: #4
5.5
—
-500,000 -16.7%
P
S
2,485,448 $221,279,435
$24.68 +280.2%
$89.03 +5.4%
2023 Q4 13F Filing 2026-09-30 2026-11-16
KRSA
KORSANA BIOSCIE...
Healthcare 7.07% — #4
Prev: #—
6.8
—
4,549,585 —
NEW
4,549,585 $145,586,720 2026 Q3 13F Filing 2026-09-30 2026-11-16
SVRA
SAVARA INC
Healthcare 4.91% 2.75% #5 3
Prev: #8
5.0
—
4,822,591 32.7%
P
S
19,568,534 $100,973,635 2022 Q1 13F Filing 2026-09-30 2026-11-16
OCUL
OCULAR THERAPEU...
Healthcare 3.86% 3.08% #6
Prev: #6
2.5
—
no change no change
P
S
10,346,926 $79,360,922 2023 Q4 13F Filing 2026-09-30 2026-11-16
N/A
DAMORA THERAPEU...
Unknown 3.73% — #7
Prev: #—
5.0
—
3,603,595 —
NEW
3,603,595 $76,684,502 — 13F Filing 2026-09-30 2026-11-16
DNTH
DIANTHUS THERAP...
Healthcare 3.52% 3.49% #8 3
Prev: #5
1.4
—
-357,980 -30.3%
P
S
822,020 $72,378,861 2023 Q3 13F Filing 2026-09-30 2026-11-16
VRDN
VIRIDIAN THERAP...
Healthcare 3.26% 1.81% #9 2
Prev: #11
2.3
—
no change no change
P
S
3,257,917 $67,080,511 2020 Q4 13F Filing 2026-09-30 2026-11-16
VOR
VOR BIOPHARMA I...
Healthcare 2.82% 1.70% #10 2
Prev: #12
2.1
—
no change no change
P
S
3,041,719 $58,035,999 2025 Q3 13F Filing 2026-09-30 2026-11-16
COGT
COGENT BIOSCIEN...
Healthcare 2.55% 1.93% #11 1
Prev: #10
2.0
—
no change no change
P
S
1,642,166 $52,582,155 2020 Q4 13F Filing 2026-09-30 2026-11-16
ANL
ADLAI NORTYE GR...
Healthcare 2.50% 1.12% #12 7
Prev: #19
2.0
—
no change no change
P
S
3,212,731 $51,403,696 2026 Q1 13F Filing 2026-09-30 2026-11-16
JBIO
JADE BIOSCIENCE...
Healthcare 2.20% 2.17% #13 4
Prev: #9
1.9
—
no change no change
P
S
3,220,364 $45,246,114 2025 Q2 13F Filing 2026-09-30 2026-11-16
ACHV
ACHIEVE LIFE SC...
Healthcare 2.16% 0.54% #14 12
Prev: #26
3.9
—
2,751,032 100.0%
P
S
5,502,064 $44,511,698 2026 Q2 13F Filing 2026-09-30 2026-11-16
MAZE
MAZE THERAPEUTI...
Healthcare 2.04% 1.45% #15 1
Prev: #14
1.3
—
-56,418 -3.5%
P
S
1,545,616 $42,009,843 2025 Q3 13F Filing 2026-09-30 2026-11-16
ORIC
ORIC PHARMACEUT...
Healthcare 1.93% 1.42% #16
Prev: #16
0.8
—
-1,375,709 -31.8%
P
S
2,944,056 $39,656,434 2023 Q2 13F Filing 2026-09-30 2026-11-16
DYN
DYNE THERAPEUTI...
Healthcare 1.70% 1.46% #17 4
Prev: #13
1.7
—
no change no change
P
S
2,173,913 $35,021,738 2023 Q2 13F Filing 2026-09-30 2026-11-16
ADRX
ADARX PHARMACEU...
Healthcare 1.58% — #18
Prev: #—
4.1
—
1,625,793 —
NEW
1,625,793 $32,418,312 2026 Q3 13F Filing 2026-09-30 2026-11-16
N/A
CRESCENT BIOPHA...
Unknown 1.51% 1.16% #19 2
Prev: #17
1.1
—
158 0.0%
P
S
2,133,734 $31,131,179 — 13F Filing 2026-09-30 2026-11-16
RLMD
RELMADA THERAPE...
Healthcare 1.36% 1.44% #20 5
Prev: #15
2.5
—
600,745 8.8%
P
S
7,445,050 $28,067,839 2020 Q1 13F Filing 2026-09-30 2026-11-16
ZURA
ZURA BIO LTD
Healthcare 1.30% 1.15% #21 3
Prev: #18
1.5
—
no change no change
P
S
6,434,990 $26,769,558 2024 Q2 13F Filing 2026-09-30 2026-11-16
XFOR
X4 PHARMACEUTIC...
Healthcare 1.08% 0.27% #22 9
Prev: #31
3.4
—
5,709,819 295.2%
P
S
7,644,072 $22,167,809 2026 Q1 13F Filing 2026-09-30 2026-11-16
CGEM
CULLINAN THERAP...
Healthcare 1.03% 0.76% #23 1
Prev: #22
1.4
—
no change no change
P
S
1,379,965 $21,182,463 2021 Q1 13F Filing 2026-09-30 2026-11-16
SRZN
SURROZEN INC
Healthcare 0.99% 0.50% #24 4
Prev: #28
1.4
—
no change no change
P
S
632,931 $20,367,720 2025 Q1 13F Filing 2026-09-30 2026-11-16
PBLS
PARABILIS MEDIC...
Healthcare 0.98% 0.52% #25 2
Prev: #27
1.4
—
no change no change
P
S
625,000 $20,181,250 2026 Q2 13F Filing 2026-09-30 2026-11-16
ARVN
ARVINAS INC
Healthcare 0.73% — #26
Prev: #—
3.8
—
1,952,533 —
NEW
1,952,533 $15,102,843 2023 Q4 13F Filing 2026-09-30 2026-11-16
IPSC
CENTURY THERAPE...
Healthcare 0.72% 0.65% #27 4
Prev: #23
1.3
—
no change no change
P
S
8,695,652 $14,869,565 2024 Q1 13F Filing 2026-09-30 2026-11-16
ENTX
ENTERA BIO LTD
Healthcare 0.72% — #28
Prev: #—
3.8
—
5,106,337 —
NEW
5,106,337 $14,859,441 2026 Q3 13F Filing 2026-09-30 2026-11-16
ARTV
ARTIVA BIOTHERA...
Healthcare 0.71% 0.60% #29 5
Prev: #24
1.3
—
no change no change
P
S
2,043,596 $14,550,404 2024 Q3 13F Filing 2026-09-30 2026-11-16
ANRO
ALTO NEUROSCIEN...
Healthcare 0.62% 0.40% #30
Prev: #30
1.2
—
no change no change
P
S
500,000 $12,765,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
KRRO
KORRO BIO INC
Healthcare 0.21% 0.40% #31 2
Prev: #29
0.1
—
-566,069 -56.1%
P
S
443,431 $4,394,401 2026 Q1 13F Filing 2026-09-30 2026-11-16
N/A
TCGX ACQUISITIO...
Unknown 0.18% — #32
Prev: #—
3.6
—
300,000 —
NEW
300,000 $3,753,000 — 13F Filing 2026-09-30 2026-11-16
N/A
RESEARCH ALLIAN...
Unknown 0.17% — #33
Prev: #—
3.6
—
300,000 —
NEW
300,000 $3,600,000 — 13F Filing 2026-09-30 2026-11-16
INM
INMED PHARMACEU...
Healthcare 0.01% 0.00% #34 1
Prev: #33
3.0
—
100,693 308.1%
P
S
133,378 $181,394 2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
RESEARCH ALLIAN...
Unknown 0.00% 0.10%
Sold All 😨
(Was: #32)
0.0
—
-300,000 -100.0%
CLOSED
— $— — 13F Filing 2026-09-30 2026-11-16
CTMX
CYTOMX THERAPEU...
Healthcare 0.00% 0.57%
Sold All 😨
(Was: #25)
0.0
—
-4,982,124 -100.0%
CLOSED
— $— 2025 Q2 13F Filing 2026-09-30 2026-11-16
CYBN
CYBIN INC
Unknown 0.00% 0.77%
Sold All 😨
(Was: #21)
0.0
—
-3,851,654 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
ELVN
ENLIVEN THERAPE...
Healthcare 0.00% 0.81%
Sold All 😨
(Was: #20)
0.0
—
-526,331 -100.0%
CLOSED
— $— 2023 Q1 13F Filing 2026-09-30 2026-11-16
GLTO
DAMORA THERAPEU...
Healthcare 0.00% 2.84%
Sold All 😨
(Was: #7)
0.0
—
-3,603,595 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
APGE
APOGEE THERAPEU...
Healthcare 0.00% 34.18%
Sold All 😨
(Was: #1)
0.0
—
-8,493,321 -100.0%
CLOSED
— $— 2023 Q3 13F Filing 2026-09-30 2026-11-16
Showing 1-40 of 40 holdings

Unlock Full Venrock Adviser, LLC Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →